Overtreatment in children with epilepsy

Epilepsy Research

Volumn 52, Issue 1, 2002, Pages 35-42

  Holmes, Gregory L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antiepileptic drugs; Developmental delay; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

AWARENESS; BEHAVIOR; CLINICAL TRIAL; CONFERENCE PAPER; EPILEPSY; HUMAN; MEDICAL DECISION MAKING; MONOTHERAPY; MORBIDITY; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK; SEDATION; SEIZURE; TREATMENT INDICATION; UNITED STATES;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FORECASTING; HUMANS; MORBIDITY; OVERDOSE; RISK;

EID: 0036851006     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00183-3     Document Type: Conference Paper

References (83)

1. Aithal G.P., Day C.P., Kesteven P.J., Daly A.K. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 353:1999;717-719.
2. Alvarez N. Discontinuance of antiepileptic medications in patients with developmental disability and diagnosis of epilepsy. Am. J. Ment. Retard. 93:1989;593-599.
3. Alvarez N. Barbiturates in the treatment of epilepsy in people with intellectual disability. J. Intellect. Disabil. Res. 42:(Suppl. 1):1998;16-23.
4. Alvarez N., Besag F., Iivanainen M. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. J. Intellect. Disabil. Res. 42:(Suppl. 1):1998;1-15.
5. Amann J.P., Dulac O. Trials in children. Epilepsy Res. 45:2001;133-136.
6. Appleton R.E. Vigabatrin in the management of generalized seizures in children. Seizure. 4:1995;45-48.
7. Bauer J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol. Scand. 94:1996;367-377.
8. Baumann R.J. Prevention and management of febrile seizures. Paediatr. Drugs. 3:2001;585-592.
9. Baumann R.J., Duffner P.K. Treatment of children with simple febrile seizures: the AAP practice parameter. American Academy of Pediatrics. Pediatr. Neurol. 23:2000;11-17.
10. Berg A.T., Hauser W.A., Shinnar S. The prognosis of childhood-onset epilepsy. Shinnar S., Amir N., Branski D., Childhood Seizures. 1995;93-99 Karger, Basel, Switzerland.
11. Bourgeois B.F.D. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia. 39:1998;913-921.
12. Bourgeois B.F.D., Prensky A.L., Palkes H.S., Talent B.K., Busch S.G. Intelligence in epilepsy: a prospective study in children. Ann. Neurol. 14:1983;438-444.
13. Brodie M.J., McPhail E., Macphee G.J., Larkin J.G., Gray J.M. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients. Eur. J. Clin. Pharmacol. 31:1987;655-660.
14. Callahan D.J., Noetzel M.J. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology. 42:1992;2198-2201.
15. Camfield C.S., Camfield P., Gordon K., Smith B., Dooley J. Outcome of childhood epilepsy: a population-based study with a simple scoring system for those treated with medication. J. Pediatr. 122:1993;861-868.
16. Camfield C.S., Chaplin S., Doyle A.-B., Shapiro S.H., Cummings C., Camfield P.R. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J. Pediatr. 95:1979;361-365.
17. Carmant L., Kramer U., Holmes G.L., Mikati M.A., Riviello J.J., Helmers S.L. Differential diagnosis of staring spells in children: a video-EEG study. Pediatr. Neurol. 14:1996;199-202.
18. Carpay H.A., Arts W.F.M., Geerts A.T., Stoink H., Brouwer O.F., Peters A.C.B., van Donselaar C.A. Epilepsy in Childhood. An audit of Clinical Practice. Arch. Neurol. 55:1998;668-673.
19. Cavazzuti G.B., Nalin A. Psychobehavioral disturbance in epileptic children. Child's Nerv. Syst. 6:1990;430-433.
20. Chen W.T., Yen D.J., Yu H.Y., Liao K.K. Valproate-induced encephalopathy. Zhonghua Yi Xue Za Zhi (Taipei). 64:2001;474-478.
21. Chen Y., Chi C.J., Lee I. Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res. 44:2001;65-70.
22. Clancy R.R. New anticonvulsants in pediatrics: carbamazepine and valproate. Curr. Probl. Pediatr. 17:1987;133-209.
23. De Silva M., MacArdle B., McGowan M., Hughes E., Stewart J., Neville B.G., Johnson A.L., Reynolds E.H. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet. 347:1996;709-713.
24. Devinsky O. What do you do when they grow up? Approaches to seizures in developmentally delayed adults. Epilepsia. 43:(Suppl. 3):2002;71-79.
25. Dhuna A., Pascual-Leone A., Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia. 32:1991;275-278.
26. Dieckhaus C.M., Miller T.A., Sofia R.D., Macdonald T.L. A mechanistic approach to understanding species differences in felbamate bioactivation: relevance to drug-induced idiosyncratic reactions. Drug Metab. Dispos. 28:2000;814-822.
27. Donat J.F., Wright F.S. Episodic symptoms mistaken for seizures in the neurologically impaired child. Neurology. 40:1990;156-157.
28. Eldridge R., Iivanainen M., Stern R., Koerber T., Wilder B.J. Baltic myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet. 2:1983;838-842.
29. Elger C.E., Bauer J., Scherrmann J., Widman G. Aggravation of focal epileptic seizures by antiepileptic drugs. Epilepsia. 39:(Suppl. 3):1998;S15-S18.
30. Elwes R.D.C., Johnson A.L., Shorvon S.D., Reynolds E.H. The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med. 311:1984;944-947.
31. Evans W.E., Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 286:1999;487-491.
32. Farwell J.R., Lee Y.J., Hirtz D.G., Sulzbacher S.I., Ellenberg J.H., Nelson K.B. Phenobarbital for febrile seizures. Effects on intelligence and on seizure recurrence. N. Engl. J. Med. 322:1990;364-369.
33. Feely M.P., Callaghan M.N. Changing to single drug therapy in epilepsy. Lancet. 1:1981;847.
34. Ferngren H., Akerstrom I., Rane A. Mono- or polypharmacotherapy in institutionalized epileptic children with severe mental retardation? A team approach for optimizing antiepileptic therapy. Acta Paediatr. Scand. 80:1991;458-465.
35. Fischbacher E. Effect of reduction of anticonvulsants on wellbeing. Br. Med. J. (Clin. Res. Ed.). 285:1982;423-424.
36. Furuta T., Ohashi K., Kamata T., Takashima M., Kosuge K., Kawasaki T., Hanai H., Kubota T., Ishizaki T., Kaneko E. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann. Intern. Med. 129:1998;1027-1030.
37. Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev. 22:2000;75-80.
38. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia. 39:(Suppl. 3):1998;S2-S10.
39. Guerrini R., Belmonte A., Parmeggiani L., Perucca E. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev. 21:1999;420-424.
40. Guerrini R., Dravet C., Genton P., Belmonte A., Kaminska A., Dulac O. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 39:1998;508-512.
41. Hanzel T.E., Kalachnik J.E., Harder S.R. A case of phenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy. Res. Dev. Disabil. 13:1992;381-392.
42. Hauser W.A. Epidemiology of epilepsy in children. Neurosurg. Clin. North Am. 6:1995;419-429.
43. Hauser W.A., Hersdorffer D.C. Epilepsy: Frequency, Causes and Consequences. 1990;Demos, New York.
44. Herranz J.L., Armijo J.A., Artega R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia. 29:1988;794-804.
45. Holmes G.L. Myoclonic, tonic, and atonic seizures in children. J. Epilepsy. 1:1988;173-195.
46. Holmes G.L., Sackellares J.C., McKiernan J., Ragland M., Dreifuss F.E. Evaluation of childhood pseudoseizures using EEG telemetry and video tape monitoring. J. Pediatr. 97:1980;554-558.
47. Huttenlocher P.R., Hapke R.J. A follow-up study of intractable seizures in childhood. Ann. Neurol. 28:1990;699-705.
48. Janszky J., Rasonyi G., Halasz P., Olajos S., Perenyi J., Szucs A., Debreczeni T. Disabling erratic myoclonus during lamotrigine therapy with high serum level - report of two cases. Clin. Neuropharmacol. 23:2000;86-89.
49. Jones G.L., Matsuo F., Baringer J.R., Reichert W.H. Valproic acid-associated encephalopathy. West. J. Med. 153:1990;199-202.
50. Kifune A., Kubota F., Shibata N., Akata T., Kikuchi S. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves. Epilepsia. 41:2000;909-912.
51. Ko T.-S., Holmes G.L. EEG and clinical predictors of medically intractable childhood epilepsy. Clin. Neurophysiol. 110:1999;1245-1251.
52. Litzinger M.J., Duvall B., Little P. Movement of individuals with complex epilepsy from an institution into the community: seizure control and functional outcomes. Am. J. Ment. Retard. 98 Suppl. 1993;52-57.
53. MacDonald B.K., Johnson A.L., Sander J.W., Shorvon S.D. Febrile convulsions in 220 children - neurological sequelae at 12 years follow-up. Eur. Neurol. 41:1999;179-186.
54. Marciani M.G., Maschio M., Spanedda F., Iani C., Gigli G.L., Bernardi G. Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study. Acta Neurol. Scand. 91:1995;1-5.
55. Mattson R.H. The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps. Epilepsia. 37:(Suppl. 6):1996;S45-S53.
56. Mayhew L.A., Hanzel T.E., Ferron F.R., Kalachnik J.E., Harder S.R. Phenobarbital exacerbation of self-injurious behavior. J. Nerv. Ment. Dis. 180:1992;732-733.
57. Paolicchi J.M. The spectrum of nonepileptic events in children. Epilepsia. 43:(Suppl. 3):2002;60-64.
58. Parker A.P., Agathonikou A., Robinson R.O., Panayiotopoulos C.P. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Dev. Med. Child Neurol. 40:1998;517-519.
59. Pellock J.M., Hunt P.A. A decade of modern epilepsy therapy in institutionalized mentally retarded patients. Epilepsy Res. 25:1996;263-268.
60. Perucca E., Gram L., Avanzini G., Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 39:1998;5-17.
61. Poindexter A.R., Berglund J.A., Kolstoe P.D. Changes in antiepileptic drug prescribing patterns in large institutions: preliminary results of a five-year experience. Am. J. Ment. Retard. 98 Suppl. 1993;34-40.
62. Rochat P., Hallas J., Gaist D., Friis M.L. Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol. Scand. 104:2001;6-11.
63. Rodin E.A., Schmaltz S., Twitty G. Intellectual functions of patients with childhood-onset epilepsy. Dev. Med. Child Neurol. 28:1986;25-33.
64. Rosenow F., Wyllie E., Kotagal P., Mascha E., Wolgamuth B.R., Hamer H. Staring spells in children: descriptive features distinguishing epileptic and nonepileptic events. J. Pediatr. 133:1998;660-663.
65. Schmidt D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia. 24:1983;368-376.
66. Shields W.D., Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology. 33:1983;1487-1489.
67. Shinnar S., Ballaban-Gil K. An approach to the child with a first unprovoked seizure. Pediatr. Ann. 20:1991;29-33.
68. Shinnar S., Berg A.T., Moshe S.L., O'Dell C., Alemany M., Newstein D., Kang H., Goldensohn E.S., Hauser W.A. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics. 98:1996;216-225.
69. Shinnar S., Berg A.T., Moshe S.L., Petix M., Maytal J., Kang H., Goldensohn E.S., Hauser W.A. Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics. 85:1990;1076-1085.
70. Shinnar S., Glauser T.A. Febrile seizures. J. Child Neurol. 17:(Suppl. 1):2002;S44-S52.
71. Shorvon S.D., Reynolds E.H. Unnecessary polypharmacy for epilepsy. Br. Med. J. 1:1977;1635-1637.
72. Sivenius J., Savolainen S., Kaski M., Riekkinen P.J. Therapeutic intervention in mentally retarded adult epileptics. Acta Neurol. Scand. 81:1990;165-167.
73. Snead O.C., Hosey L.C. Exacerbation of seizures in children by carbamazepine. N. Engl. J. Med. 313:1985;916-921.
74. Sorel L., Dusaucy-Bauloye E. A propos de 21 cas d'hypsarhythmia de Gibbs son traitment spectaculaire par l'ACTH. Acta Neurol. Belg. 58:1958;130-141.
75. Stafstrom C.E., Holmes G.L. Infantile spasms: criteria for an animal model. Int. Rev. Neurobiol. 49:2002;391-411.
76. Tartara A., Manni R. Sodium valproate 'encephalopathy': report of three cases with generalised epilepsy. Ital. J. Neurol. Sci. 6:1985;93-95.
77. Tetto A., Manzoni P., Millul A., Beghi E., Garattini L., Tartara A., Avanzini G. The costs of epilepsy in Italy. A prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res. 48:2002;207-216.
78. Theodore W.H., Porter R.J. Removal of sedative-hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy. Ann. Neurol. 13:1983;320-324.
79. Vining E.P.G., Mellits D., Dorsen M., Cataldo M.F., Quaskey S.A., Spielberg S.Y., Freeman J. Psychological and behavioral effects of antiepileptic drugs in children: a double blind comparison between phenobarbital and valproic acid. Pediatrics. 80:1987;165-174.
80. Wilder B.J. Drug therapy for seizures. Clin. Ther. 7:1985;246-253.
81. Wilkinson I.A., Murphy J.V., Georgeson R., D'Souza B.J. On-site seizure clinic: impact on th welfare of mentally retarded, institutionalized patients. Arch. Neurol. 39:1982;41-43.
82. Wilson E.A., Sills G.J., Forrest G., Brodie M.J. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Res. 29:1998;161-166.
83. Wyllie E., Friedman D., Rothner A.D., Luders H., Dinner D., Morris H. III, Cruse R., Erenberg G., Kotagal P. Psychogenic seizures in children and adolescents: outcome after diagnosis by ictal video and electroencephalographic recording. Pediatrics. 85:1990;480-484.